Citigroup Inc Bristol Myers Squibb CO Call Options Transaction History

Citigroup Inc

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $40,250 - $52,990	-1,000 Reduced 3.85%	25,000 $1.04 Million
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $10.2 Million - $11.6 Million	-213,000 Reduced 89.12%	26,000 $1.41 Million
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $489,647 - $584,285	10,100 Added 4.41%	239,000 $12.3 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $694,680 - $776,760	12,000 Added 5.53%	228,900 $13.3 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $2.01 Million - $2.23 Million	31,500 Added 16.99%	216,900 $13.9 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $13.5 Million - $15.3 Million	-205,200 Reduced 52.53%	185,400 $12.9 Million
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $17.2 Million - $20.4 Million	-251,600 Reduced 39.18%	390,600 $28.1 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $55,666 - $32.9 Million	428,200 Added 200.09%	642,200 $45.7 Million
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $44.4 Million - $48.9 Million	-610,800 Reduced 74.05%	214,000 $16.5 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $8.59 Million - $10.3 Million	139,800 Added 20.41%	824,800 $60.2 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $9.1 Million - $10.6 Million	169,700 Added 32.93%	685,000 $42.7 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $30.5 Million - $35.7 Million	515,300 New	515,300 $30.5 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.